Journal List > Yonsei Med J > v.51(2) > 1030607

Park, Sir, Park, Kim, Lee, Kwak, Cho, and Choi: Acute Idiopathic Hemorrhagic Pericarditis with Cardiac Tamponade as the Initial Presentation of Acquired Immune Deficiency Syndrome

Abstract

This paper presents a case of cardiac tamponade with idiopathic hemorrhagic pericarditis as the initial symptom of human immunodeficiency virus (HIV) infection. A 29-year-old male came to the emergency room with a sudden onset of dizziness. Upon arrival, he was hypotensive although not tachycardic, and his jugular venous pressure was not elevated. His chest X-rays revealed a mild cardiomegaly. Transthoracic echocardiography revealed a large amount of pericardial effusion with a diastolic collapse of the right ventricle, a dilated inferior vena cava with little change in respiration, and exaggerated respiratory variation of mitral inflow velocities, representing echocardiographic evidence of cardiac tamponade. After pericardiocentesis, his blood pressure improved to 110/70 mmHg without inotropics support. Serial 12-lead electrocardiograms during hospitalization revealed upwardly concave diffuse ST-segment elevation followed by a T-wave inversion suggestive of acute pericarditis. Pericardial fluid cytology and cultures for bacteria, mycobacteria, adenovirus, and fungus were all negative. HIV enzyme-linked immunosorbent assay (ELISA) was positive and confirmed by Western blot. The CD4 cell count was 168/mm3. Finally, the diagnosis of cardiac tamponade due to HIV-associated hemorrhagic pericarditis was made. It was concluded that HIV infection should be considered in the diagnosis of unexplained pericardial effusion or cardiac tamponade in Korea.

INTRODUCTION

Pericardial effusion is one of the most common cardiac manifestations of human immunodeficiency virus (HIV) infection.1 Pericarditis is found during autopsy in 30% of AIDS patients and pericardial effusions have been detected in about 20% of HIV-infected patients.1,2 In patients with HIV infection, pericardial symptoms and clinical signs may be the first indication of cardiac disease without the presence of other clinical symptoms of HIV infection.3 Therefore, HIV infection should be included in the differential diagnosis of unexplained pericardial effusion or tamponade.4 In this report, we present an exceptionally rare case of cardiac tamponade as the first symptom of HIV infection, which has not been previously reported in Korea.

CASE REPORT

A previously healthy 29-year-old heterosexual man was admitted to the emergency room of our hospital due to a sudden onset of dizziness with presyncope. Dizziness was accompanied by palpitation, nausea, and vomiting. He also complained of a two-week duration of dull, substernal chest discomfort, which was neither pleuritic nor related to exertion, swallowing, or position change. He denied a past medical history of intravenous drug abuse or blood transfusion. A physical examination revealed an acute ill-looking appearance, cachexia, dehydration, and cool extremities. His vital signs were as follows: blood pressure 60/30 mmHg, pulse rate 71 beats/min, respiratory rate 22/min, and body temperature 36.5℃. Initially, he had no peripheral edema and jugular venous pressure was not elevated. No lymphadenopathy or oral thrush was found. Pulsus paradoxus was not measured. A chest examination revealed clear breath sounds. The heart sounds were normal. No pericardial rub was audible. The abdomen was not tender and was without organomegaly or ascites. A chest X-ray demonstrated a slightly enlarged cardiac silhouette with normal lung fields (Fig. 1). A 12-lead electrocardiogram (ECG) revealed a normal sinus rhythm at 71 beats/min and non-specific ST-segment abnormalities (Fig. 2A). Laboratory data showed a hemoglobin level of 13.9 g/dL, a white blood cell count of 8,010/mm3 (50.5% neutrophils, 42.8% lymphocytes), platelet count of 175,000/mm3, creatine kinase-MB isoenzyme 1.7 ng/mL, pro-B-type natriuretic peptide 506.3 pg/mL, creatinine 1.4 mg/dL, alkaline phosphatase 97 IU/L, aminoaspartate transaminase 29 U/L, alanine transaminase 30 U/L, erythrocyte sedimentation rate 1 mm/h, and C-reactive protein 0.4 mg/dL. The arterial blood gas results were pH 7.50 mmHg, PO2 90.9 mmHg, PCO2 20 mmHg, and HCO3 15.7 mmol/L. With vigorous intravenous hydration of 2 liters of normal saline during a 2 hour period, jugular veins became progressively distended and jugular venous pressure was elevated. However, the patient remained hypotensive and oliguria persisted. In view of the hypotension and raised jugular venous pressure, the possibility of cardiac tamponade was considered. A large pericardial effusion with the collapse of the right ventricle during diastole was noted on the transthoracic echocardiography (Fig. 3A). The inferior vena cava was dilated with little or no change in respiration. A pulse-wave Doppler study disclosed exaggerated respiratory variation of the mitral inflow velocities consistent with cardiac tamponade physiology (Fig. 3B). Consequently, a total of 900 mL of hemorrhagic pericardial effusion was aspirated by apical pericardiocentesis. After pericardiocentesis, the blood pressure improved to 110/70 mmHg without inotropics support. Pericardial fluid cytology and cultures for bacteria, mycobacteria, adenovirus, and fungus were all negative. Blood and urine cultures were also sterile. A serial 12-lead ECG during hospitalization revealed diffuse upward concave ST-segment elevation and PR-segment depression, suggestive of acute pericarditis (Fig. 2B). Serological tests using antibodies to cytomegalovirus, herpes simplex virus, Epstein-Barr virus, influenza virus types A and B, adenovirus, Coxsackie virus types B1, B2, B3, B4 and B5, parainfluenza virus types 1, 2, 3, 4, hepatitis A, B and C virus, Legionella spp., Mycoplasma spp., and Cryptococcus spp. showed no evidence of recent infection. However, HIV infection was detected by an enzyme-linked immunosorbent assay and confirmed by Western blot. The CD4 cell count was 168 cells/mm3. Finally, the diagnosis of cardiac tamponade with HIV-associated hemorrhagic pericarditis was made. On the seventh day of hospitalization, the ECG showed nearly complete resolution of the ST-segment elevation, which was followed by T wave inversion (Fig. 2C). The pericardial drain was removed after four days, with the cessation of drainage. An echocardiogram performed on the tenth day of hospitalization showed small amounts of residual pericardial effusion which did not increase. ECG also normalized (Fig. 2D). On the eleventh day of hospitalization, the patient was discharged in stable condition.

DISCUSSION

To our knowledge, this is the first reported case of cardiac tamponade due to HIV-associated pericarditis in Korea. In our patient, pericardial symptoms and clinical signs were the first clinical findings in the course of HIV infection. In such a young patient with minimal coronary risk factors who nevertheless has a history of acute chest pain, ECG findings such as sinus tachycardia, diffuse ST-segment elevation, and low QRS amplitude may suggest acute pericarditis. Echocardiography performed at the bedside may be the most appropriate diagnostic procedure to detect pericardial effusion and to rule out cardiac tamponade in HIV infection.5 The prevalence of cardiac involvement in Acquired Immune Deficiency Syndrome (AIDS) patients has been reported in as many as 45% to 66% of people infected.6 In most patients with HIV, the effusions are small and most patients are asymptomatic.7,8 The reported cases of cardiac tamponade in HIV patients showed hypotension, jugular venous distention, tachycardia, and edema.9 However, our patient initially did not have these clinical signs of cardiac tamponade such as tachycardia, jugular venous distention, or edema. These signs may be absent in patients with "low-pressure tamponade".9 Patients with intravascular fluid depletion due to dehydration, cachexia, and wasting states associated with advanced AIDS may have low pericardial pressure tamponade. Therefore, in patients with pericardial effusion accompanied by clinical signs of hemodynamic embarrassment, cardiac tamponade should be ruled out and pericardiocentesis should be considered, even with the absence of typical clinical signs of cardiac tamponade.10
In conclusion, cardiac tamponade can be the first presentation of HIV infection. It must be considered for the presence of unexplained pericardial effusion or cardiac tamponade.

Figures and Tables

Fig. 1
Chest X-ray obtained on arrival showing mild cardiomegaly.
ymj-51-273-g001
Fig. 2
(A) A 12-lead electrocardiogram obtained on arrival showing normal sinus rhythm and non-specific ST-segment abnormalities. (B) A 12-lead electrocardiogram on the second day showing widespread upward concave ST-segment elevation (arrowheads) as well as PR-segment depression (arrows). (C) A 12-lead electrocardiogram showing normalized ST-segment with T-wave inversion (arrowheads). (D) A 12-lead electrocardiogram with a normalized ST-segment.
ymj-51-273-g002
Fig. 3
(A) A 2D-transthoracic echocardiogram performed in subcostal four-chamber view showing a large amount of pericardial effusion with right ventricular collapse, indicative of cardiac tamponade. (B) A pulsed-wave Doppler study of flow across the mitral valve showing exaggerated respiratory variation in the mitral inflow E-wave, indicative of tamponade. The arrowheads denote expiration and the asterisks denote inspiration. RA, right atrium; PE, pericardial effusion; RV, right ventricle.
ymj-51-273-g003

Notes

The authors have no financial conflicts of interest.

References

1. Katz AS, Sadaniantz A. Echocardiography in HIV cardiac disease. Prog Cardiovasc Dis. 2003. 45:285–292.
crossref
2. Cammarosano C, Lewis W. Cardiac lesions in acquired immune deficiency syndrome (AIDS). J Am Coll Cardiol. 1985. 5:703–706.
crossref
3. d'Amati G, di Gioia CR, Gallo P. Pathological findings of HIV-associated cardiovascular disease. Ann N Y Acad Sci. 2001. 946:23–45.
4. Barbaro G. Cardiovascular manifestations of HIV infection. Circulation. 2002. 106:1420–1425.
5. Himelman RB, Chung WS, Chernoff DN, Schiller NB, Hollander H. Cardiac manifestations of human immunodeficiency virus infection: a two-dimensional echocardiographic study. J Am Coll Cardiol. 1989. 13:1030–1036.
6. Cotter BR. Epidemiology of HIV cardiac disease. Prog Cardiovasc Dis. 2003. 45:319–326.
crossref
7. Heidenreich PA, Eisenberg MJ, Kee LL, Somelofski CA, Hollander H, Schiller NB, et al. Pericardial effusion in AIDS. Incidence and survival. Circulation. 1995. 92:3229–3234.
8. Silva-Cardoso J, Moura B, Martins L, Mota-Miranda A, Rocha-Gonçalves F, Lecour H. Pericardial Involvement in Human Immunodeficiency Virus Infection. Chest. 1999. 115:418–422.
crossref
9. Gowda RM, Khan IA, Sacchi TJ, Vasavada BC. Cardiac tamponade in acquired immunodeficiency syndrome. Int J Cardiol. 2003. 88:313–314.
crossref
10. Sagristà-Sauleda J, Angel J, Sambola A, Alguersuari J, Permanyer-Miralda G, Soler-Soler J. Low-pressure cardiac tamponade: clinical and hemodynamic profile. Circulation. 2006. 114:945–952.
TOOLS
Similar articles